NHL Therapeutics Market Poised for 8% CAGR Through 2034: Early...

blog ekledi Botanik

2025-11-27 16:26:59

NHL Therapeutics Market Poised for 8% CAGR Through 2034: Early Diagnosis and Innovation Drive Expansion

The global Non-Hodgkin’s Lymphoma (NHL) Therapeutics Market is entering a high-growth phase driven by rising cancer incidence, rapid advancements in immunotherapy, and extensive drug development pipelines. Valued at US$ 8.0 billion in 2023, the market is projected to reach US$ 18.6 billion by 2034, expanding at a robust CAGR of 8.0% from 2024 to 2034. With a growing elderly population and...

0 Yorumlar 0 Paylaşımlar 44 Görüntülenme 0 İncelemeler